Literature DB >> 32042992

Patients with ankylosing spondylitis suffering from AO Type B3 traumatic thoracolumbar fractures are associated with increased frailty and morbidity when compared with patients with diffuse idiopathic skeletal hyperostosis.

Terence Tan1,2, Milly S Huang1,2, Martin K Hunn1, Jin Tee1,2.   

Abstract

BACKGROUND: AO Type B3 hyperextension thoracolumbar fractures are the commonest fracture subtype in ankylosing spinal disorders. Although often considered together in spinal fractures, ankylosing spondylitis (AS) and diffuse idiopathic skeletal hyperostosis (DISH) are distinct spondyloarthropathies with different pathophysiology. Few studies have compared the two entities in the setting of traumatic thoracolumbar fractures. The authors compare demographic metrics, injury profile, clinical and radiographical outcomes between patients with AS and DISH in patients suffering from AO Type B3 traumatic thoracolumbar fractures.
METHODS: From January 2008 to December 2018, a retrospective analysis of consecutive surgically-managed patients with AO Type B3 fractures was performed. Demographic metrics, co-morbidity [Charlson-comorbidity index, modified frailty index (mFI), etc.], injury profile (level of injury, mechanism of injury, etc.), clinical (postoperative complication, etc.) and radiographical variables were collected. Differences between patients with AS and DISH were compared.
RESULTS: Fourteen patients were identified. All patients had AS (n=6) or DISH (n=8). The mean age was 72.8±10.2 years and 78.6% of patients were neurologically intact at presentation. Medical and/or surgical complications occurred in 10 of 14 (71.4%) patients. As compared to patients with DISH, patients with AS were more likely to have low falls as the injury mechanism [odds ratio (OR): 35.0, P=0.026], have higher mFI (OR: 30.6, P=0.015), and experience a higher number of postoperative complications per patient (AS: 1.8/patient vs. DISH: 0.5/patient, P=0.024).
CONCLUSIONS: In the setting of AO Type B3 fractures, patients with AS are more frail and have higher in-hospital morbidity compared to patients with DISH. Despite both pathologies being ankylosing in nature, further studies are required to fully understand the clinical differences between the two entities to enable clinicians to apply a more targeted and nuanced approach in managing fractures in ankylosing spinal disorders. 2019 Journal of Spine Surgery. All rights reserved.

Entities:  

Keywords:  AO Type B3; ankylosing spondylitis (AS); diffuse idiopathic skeletal hyperostosis (DISH); surgical management; thoracolumbar fracture

Year:  2019        PMID: 32042992      PMCID: PMC6989928          DOI: 10.21037/jss.2019.09.11

Source DB:  PubMed          Journal:  J Spine Surg        ISSN: 2414-4630


  12 in total

1.  Clinical outcome after traumatic spinal fractures in patients with ankylosing spinal disorders compared with control patients.

Authors:  L A Westerveld; J C van Bemmel; W J A Dhert; F C Oner; J J Verlaan
Journal:  Spine J       Date:  2013-08-27       Impact factor: 4.166

Review 2.  Radiographic measurement parameters in thoracolumbar fractures: a systematic review and consensus statement of the spine trauma study group.

Authors:  Ory Keynan; Charles G Fisher; Alexander Vaccaro; Michael G Fehlings; F C Oner; John Dietz; Brian Kwon; Raj Rampersaud; Christopher Bono; John France; Marcel Dvorak
Journal:  Spine (Phila Pa 1976)       Date:  2006-03-01       Impact factor: 3.468

3.  Use of the modified frailty index to predict 30-day morbidity and mortality from spine surgery.

Authors:  Rushna Ali; Jason M Schwalb; David R Nerenz; Heath J Antoine; Ilan Rubinfeld
Journal:  J Neurosurg Spine       Date:  2016-05-06

4.  Ground level falls are associated with significant mortality in elderly patients.

Authors:  Konstantinos Spaniolas; Julius D Cheng; Mark L Gestring; Ayodele Sangosanya; Nicole A Stassen; Paul E Bankey
Journal:  J Trauma       Date:  2010-10

5.  Are the frail destined to fail? Frailty index as predictor of surgical morbidity and mortality in the elderly.

Authors:  Joseph S Farhat; Vic Velanovich; Anthony J Falvo; H Mathilda Horst; Andrew Swartz; Joe H Patton; Ilan S Rubinfeld
Journal:  J Trauma Acute Care Surg       Date:  2012-06       Impact factor: 3.313

6.  Spinal Fracture in Patients With Ankylosing Spondylitis: Cohort Definition, Distribution of Injuries, and Hospital Outcomes.

Authors:  Adam M Lukasiewicz; Daniel D Bohl; Arya G Varthi; Bryce A Basques; Matthew L Webb; Andre M Samuel; Jonathan N Grauer
Journal:  Spine (Phila Pa 1976)       Date:  2016-02       Impact factor: 3.468

Review 7.  A review of the pathogenesis of ankylosing spondylitis.

Authors:  Elias Dakwar; Jaypal Reddy; Fernando L Vale; Juan S Uribe
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

Review 8.  Complications of the spine in ankylosing spondylitis with a focus on deformity correction.

Authors:  Matthew L Mundwiler; Khawar Siddique; Jeffrey M Dym; Brian Perri; J Patrick Johnson; Michael H Weisman
Journal:  Neurosurg Focus       Date:  2008       Impact factor: 4.047

Review 9.  Spinal fractures in patients with ankylosing spinal disorders: a systematic review of the literature on treatment, neurological status and complications.

Authors:  L A Westerveld; J J Verlaan; F C Oner
Journal:  Eur Spine J       Date:  2008-09-13       Impact factor: 3.134

Review 10.  Diffuse idiopathic skeletal hyperostosis (DISH): where we are now and where to go next.

Authors:  Reuven Mader; Jorrit-Jan Verlaan; Iris Eshed; Jacome Bruges-Armas; Piercarlo Sarzi Puttini; Fabiola Atzeni; Dan Buskila; Eyal Reinshtein; Irina Novofastovski; Abdallah Fawaz; de Vlam Kurt; Xenofon Baraliakos
Journal:  RMD Open       Date:  2017-06-21
View more
  1 in total

1.  Association of Continuous Vertebral Bone Bridges and Bone Mineral Density with the Fracture Risk in Patients with Diffuse Idiopathic Skeletal Hyperostosis.

Authors:  Mitsuru Furukawa; Kunimasa Okuyama; Ken Ninomiya; Yoshiyuki Yato; Takeshi Miyamoto; Masaya Nakamura; Morio Matsumoto
Journal:  Asian Spine J       Date:  2021-05-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.